Clinicians across the United States are rationing the only long-acting penicillin approved for syphilis treatment after the ...
Bicillin—a common form of penicillin manufactured by Pfizer and used to treat syphilis—is the newest antibiotic to face a shortage, causing the drugmaker to recommend the use of an alternative, less ...
Nov. 30, 2004 — The U.S. Food and Drug Administration (FDA) and King Pharmaceuticals, Inc., have notified healthcare professionals via letter of labeling changes for existing prescribing and route of ...
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during ...
For this story, Boodman obtained email chains between Pfizer and health officials and conducted interviews with 10 state health departments, eight local health agencies, six health system pharmacists, ...
The preferred antibiotic treatment for syphilis is in short supply across the United States as infections soar, and more than three dozen leading public health groups are urging the White House to ...
Penicillin G benzathine, penicillin G procaine equal amounts; combined penicillin G dose 600,000 units/mL; susp for deep IM inj; contains parabens. Give by deep IM inj into upper, outer buttock ...
LOS ANGELES--(BUSINESS WIRE)--As reported cases of sexually transmitted diseases continue to rise across the U.S., AIDS Healthcare Foundation (AHF) today sharply criticized the U.S. biopharmaceutical ...
Pfizer is facing a shortage of penicillin due to increased demand and more diagnoses of syphilis, the company said in a letter to its customers this week. The company said there is an "impending stock ...
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during ...